通过LAT1识别抗癌药物和氨基酸运输的结构基础
Yongchan Lee1,2, Chunhuan Jin3, Ryuichi Ohgaki3,4
1Department of Structural Biology, Max Planck Institute of Biophysics, 60438, Frankfurt, Germany. yongchan.lee@biophys.mpg.de.
结构洞察力揭示了LAT1 (SLC7A5) 如何运输氨基酸,并被像JPH203.3这样的药物抑制. 了解这些机制是癌症治疗和药物输送进步的关键.
科学领域:
- 生物化学 生物化学
- 结构生物学 结构生物学
- 分子运输分子的运输.
背景情况:
- 氨基酸载体LAT1 (SLC7A5) 对癌细胞生长,免疫反应和药物输送至关重要.
- 了解LAT1的基质歧视和抑制机制至关重要,特别是对于临床相关的药物.
研究的目的:
- 阐明LAT1基质运输和抑制背后的结构机制.
- 为LAT1如何识别生理基质和治疗抑制剂提供分子基础.
主要方法:
- 确定六个晶体结构的LAT1在三个不同的形状与各种连接体结合.
- 分析连接体诱导的构造变化及其对输送器功能的影响.
主要成果:
- 抗癌药物JPH203将LAT1捕获到面向外的U形形状,与基质结合状态不同.
- 像ʟ-Phe这样的生理基质不会诱导这些特定的形状变化,而梅尔法兰则通过硬质障碍抑制.
- 抑制剂BCH诱导了一个封闭状态,证实其与LAT1.1的基质类相互作用.
结论:
- 这些结构为LAT1的基质识别和抑制机制提供了前所未有的洞察力.
- 这些发现为设计用于癌症治疗和改善药物输送的新型LAT1向药物的结构性基础.
更多相关视频
09:53Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens
Published on: February 6, 2017
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
相关概念视频
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
ABC Transporters: Exporter
ABC Transporters: Importer
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
The Significance of Membrane Transport
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
Active Transport
Primary active transporters, like Na+, K+ and -ATPase, directly utilize ATP to move ions across the membrane. These transporters play significant roles in various physiological processes. For instance, Na+, K+ and -ATPase maintain...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
